Spruce Biosciences Announces Poster Presentations at the 2024 Annual Meeting of the Endocrine Society May 22, 2024 04:14PM
Spruce Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates May 13, 2024 04:01PM
Spruce Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates Nov 13, 2023 04:05PM
Spruce Biosciences to Participate in the Jefferies London Healthcare Conference Nov 2, 2023 04:05PM
Spruce Biosciences Completes Target Enrollment of CAHmelia-203 Study in Adult Classic Congenital Adrenal Hyperplasia Oct 18, 2023 08:00AM
View Older Stories

Aug 28, 2023 04:00PM Spruce Biosciences to Participate in the H.C. Wainwright 25th Annual Global Investment Conference
Aug 14, 2023 04:00PM Spruce Biosciences Reports Second Quarter 2023 Financial Results and Provides Corporate Updates
Jun 12, 2023 04:00PM Spruce Biosciences Announces Acceptance of Abstract for Presentation at the Annual Meeting of the Endocrine Society (ENDO 2023)
May 25, 2023 08:05AM Spruce Biosciences (SPRB) Appoints Percival Barretto-Ko to its Board
May 25, 2023 08:00AM Spruce Biosciences Appoints Percival Barretto-Ko to Board of Directors
May 24, 2023 04:05PM Spruce Biosciences to Participate in the Jefferies Healthcare Conference
May 22, 2023 09:30AM Spruce Biosciences Honored at CARES Foundation 15th Annual Everyone CARES Gala
May 15, 2023 08:00AM Spruce Biosciences Reports First Quarter 2023 Financial Results and Provides Corporate Updates
May 4, 2023 04:05PM Spruce Biosciences to Present Findings on Retrospective Analysis of Completion Rates for CAH Studies at Pediatric Endocrine Society 2023 Annual Meeting
May 2, 2023 04:05PM Spruce Biosciences to Participate in May Investor Conferences
Mar 16, 2023 04:00PM Spruce Biosciences Reports Full Year 2022 Financial Results and Provides Corporate Updates
Feb 28, 2023 04:05PM Spruce Biosciences to Participate in the Oppenheimer 33rd Annual Healthcare Conference
Feb 1, 2023 04:05PM Spruce Biosciences to Participate in the SVB Securities Global Biopharma Conference
Jan 9, 2023 08:05AM Spruce Biosciences Provides Clinical Program Updates and Outlines Anticipated Milestones for 2023
Jan 5, 2023 04:00PM Spruce Biosciences (SPRB), Kaken Pharmaceutical Announce Strategic Partnership and Exclusive Licensing Agreement to Develop and Commercialize Tildacerfont for CAH in Japan
Jan 5, 2023 04:00PM Spruce Biosciences and Kaken Pharmaceutical Announce Strategic Partnership and Exclusive Licensing Agreement to Develop and Commercialize Tildacerfont for CAH in Japan
Nov 10, 2022 04:01PM Spruce Biosciences Reports Third Quarter 2022 Financial Results and Provides Corporate Updates
Oct 26, 2022 04:05PM Spruce Biosciences to Participate in November Investor Conferences
Aug 30, 2022 04:05PM Spruce Biosciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Aug 10, 2022 04:05PM Spruce Biosciences Reports Second Quarter 2022 Financial Results and Provides Corporate Update
Jun 1, 2022 04:01PM Spruce Biosciences to Participate in June Investor Conferences
May 31, 2022 08:00AM Spruce Biosciences Announces Acceptance of Abstract for Presentation at ENDO 2022 Annual Conference
May 11, 2022 04:01PM Spruce Biosciences Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 3, 2022 04:05PM Spruce Biosciences to Participate in May Investor Conferences
Apr 11, 2022 08:00AM Spruce Biosciences Appoints Libbie Mansell, Ph.D., M.B.A., R.A.C., as Chief Regulatory and Quality Officer
Mar 14, 2022 04:05PM Spruce Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Updates
Mar 14, 2022 04:01PM Spruce Biosciences (SPRB) Appoints Will Charlton as Chief Medical Officer
Mar 14, 2022 04:01PM Spruce Biosciences Appoints Will Charlton, M.D., M.A.S., as Chief Medical Officer
Mar 1, 2022 04:05PM Spruce Biosciences to Participate in March Investor Conferences
Feb 3, 2022 04:05PM Spruce Biosciences to Participate in the SVB Leerink 11th Annual Global Healthcare Conference
Jan 24, 2022 08:02AM Spruce Biosciences (SPRB) Provides Clinical Program Updates and Outlook for 2022
Jan 24, 2022 08:00AM Spruce Biosciences Provides Clinical Program Updates and Outlook for 2022
Jan 5, 2022 08:01AM Spruce Biosciences (SPRB) Appoints Javier Szwarcberg, M.D., MPH as Chief Executive Officer
Jan 5, 2022 08:00AM Spruce Biosciences Appoints Javier Szwarcberg, M.D., MPH as Chief Executive Officer
Nov 18, 2021 04:05PM Spruce Biosciences to Participate in the Piper Sandler 33rd Annual Healthcare Conference
Nov 15, 2021 04:05PM Spruce Biosciences Reports Third Quarter 2021 Financial Results and Provides Corporate Updates
Nov 15, 2021 04:03PM Spruce Biosciences (SPRB) Appoints Mike Grey as New Interim CEO
Nov 15, 2021 04:01PM Spruce Biosciences Appoints Mike Grey as Interim CEO
Sep 7, 2021 04:05PM Spruce Biosciences to Participate in September Investor Conferences
Aug 25, 2021 09:00AM Spruce Biosciences Announces Pediatric Classic CAH Program Details During Virtual R&D Day
Aug 11, 2021 04:05PM Spruce Biosciences to Host Virtual R&D Day on August 25, 2021
Aug 10, 2021 04:05PM Spruce Biosciences Reports Second Quarter 2021 Financial Results and Provides Corporate Updates
Jun 24, 2021 08:03AM Spruce Biosciences (SPRB) Appoints Kirk Ways to its Board
Jun 24, 2021 08:02AM Spruce Biosciences Appoints Renowned Drug Developer Kirk Ways, M.D., Ph.D. to Board of Directors
Jun 21, 2021 08:05AM Spruce Biosciences (SPRB) Announces Publication of Phase 2 Results for Tildacerfont in Journal of Clinical Endocrinology and Metabolism
Jun 21, 2021 08:03AM Spruce Biosciences Announces Publication of Phase 2 Results for Tildacerfont in Journal of Clinical Endocrinology and Metabolism
May 24, 2021 08:07AM Spruce Biosciences (SPRB) Presents Phase 2 Data for Tildacerfont in Adults with Congenital Adrenal Hyperplasia at 23rd European Congress of Endocrinology
May 24, 2021 08:01AM Spruce Biosciences Presents Phase 2 Data for Tildacerfont in Adults with Congenital Adrenal Hyperplasia at 23rd European Congress of Endocrinology
May 13, 2021 04:05PM Spruce Biosciences to Participate in the RBC Capital Markets Global Healthcare Conference
May 12, 2021 04:05PM Spruce Biosciences Reports First Quarter 2021 Financial Results and Provides Corporate Updates
View Older Stories